These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 34582029)

  • 1. Preclinical assessment of nanostructured liquid crystalline particles for the management of bacterial keratitis: in vivo and pharmacokinetics study.
    Kaul S; Nagaich U; Verma N
    Drug Deliv Transl Res; 2022 Jul; 12(7):1719-1737. PubMed ID: 34582029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigating nanostructured liquid crystalline particles as prospective ocular delivery vehicle for tobramycin sulfate:
    Kaul S; Nagaich U; Verma N
    J Adv Pharm Technol Res; 2021; 12(4):356-361. PubMed ID: 34820309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Self-assembled liquid crystalline nanoparticles as a novel ophthalmic delivery system for dexamethasone: Improving preocular retention and ocular bioavailability.
    Gan L; Han S; Shen J; Zhu J; Zhu C; Zhang X; Gan Y
    Int J Pharm; 2010 Aug; 396(1-2):179-87. PubMed ID: 20558263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimization of hyaluronan-enriched cubosomes for bromfenac delivery enhancing corneal permeation: characterization, ex vivo, and in vivo evaluation.
    Shoman NA; Gebreel RM; El-Nabarawi MA; Attia A
    Drug Deliv; 2023 Dec; 30(1):2162162. PubMed ID: 36587627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delineating penetration enhancer-enriched liquid crystalline nanostructures as novel platforms for improved ophthalmic delivery.
    El-Gendy MA; Mansour M; El-Assal MIA; Ishak RAH; Mortada ND
    Int J Pharm; 2020 May; 582():119313. PubMed ID: 32283196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro and in vivo evaluation of cubosomal nanoparticles as an ocular delivery system for fluconazole in treatment of keratomycosis.
    Nasr M; Teiama M; Ismail A; Ebada A; Saber S
    Drug Deliv Transl Res; 2020 Dec; 10(6):1841-1852. PubMed ID: 32779112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liquid Crystalline Nanoparticles as an Ophthalmic Delivery System for Tetrandrine: Development, Characterization, and In Vitro and In Vivo Evaluation.
    Liu R; Wang S; Fang S; Wang J; Chen J; Huang X; He X; Liu C
    Nanoscale Res Lett; 2016 Dec; 11(1):254. PubMed ID: 27188974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cubic liquid crystalline nanoparticles: optimization and evaluation for ocular delivery of tropicamide.
    Verma P; Ahuja M
    Drug Deliv; 2016 Oct; 23(8):3043-3054. PubMed ID: 26878398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation and Evaluation of Cubosomes/Cubosomal Gels for Ocular Delivery of Beclomethasone Dipropionate for Management of Uveitis.
    Gaballa SA; El Garhy OH; Moharram H; Abdelkader H
    Pharm Res; 2020 Sep; 37(10):198. PubMed ID: 32968868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel vehicle based on cubosomes for ophthalmic delivery of flurbiprofen with low irritancy and high bioavailability.
    Han S; Shen JQ; Gan Y; Geng HM; Zhang XX; Zhu CL; Gan L
    Acta Pharmacol Sin; 2010 Aug; 31(8):990-8. PubMed ID: 20686524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanostructured lipid carriers as novel ophthalmic delivery system for mangiferin: improving in vivo ocular bioavailability.
    Liu R; Liu Z; Zhang C; Zhang B
    J Pharm Sci; 2012 Oct; 101(10):3833-44. PubMed ID: 22767401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ocular Cubosome Drug Delivery System for Timolol Maleate: Preparation, Characterization, Cytotoxicity, Ex Vivo, and In Vivo Evaluation.
    Huang J; Peng T; Li Y; Zhan Z; Zeng Y; Huang Y; Pan X; Wu CY; Wu C
    AAPS PharmSciTech; 2017 Nov; 18(8):2919-2926. PubMed ID: 28429294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigating The Retention Potential of Chitosan Nanoparticulate Gel: Design, Development,
    Kaul S; Jain N; Pandey J; Nagaich U
    Recent Pat Antiinfect Drug Discov; 2020; 15(1):41-67. PubMed ID: 31612834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vancomycin ocular delivery systems based on glycerol monooleate reversed hexagonal and reversed cubic liquid crystalline phases.
    Milak S; Chemelli A; Glatter O; Zimmer A
    Eur J Pharm Biopharm; 2019 Jun; 139():279-290. PubMed ID: 31002864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation and in vitro-in vivo evaluation of ofloxacin loaded ophthalmic nano structured lipid carriers modified with chitosan oligosaccharide lactate for the treatment of bacterial keratitis.
    Ustündağ-Okur N; Gökçe EH; Bozbıyık Dİ; Eğrilmez S; Ozer O; Ertan G
    Eur J Pharm Sci; 2014 Oct; 63():204-15. PubMed ID: 25111119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Formulation and development of bicontinuous nanostructured liquid crystalline particles of efavirenz.
    Avachat AM; Parpani SS
    Colloids Surf B Biointerfaces; 2015 Feb; 126():87-97. PubMed ID: 25543986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design of Besifloxacin HCl-Loaded Nanostructured Lipid Carriers:
    Polat HK; Kurt N; Aytekin E; Akdağ Çaylı Y; Bozdağ Pehlivan S; Çalış S
    J Ocul Pharmacol Ther; 2022; 38(6):412-423. PubMed ID: 35675672
    [No Abstract]   [Full Text] [Related]  

  • 18. Self-assembled nano-architecture liquid crystalline particles as a promising carrier for progesterone transdermal delivery.
    Elgindy NA; Mehanna MM; Mohyeldin SM
    Int J Pharm; 2016 Mar; 501(1-2):167-79. PubMed ID: 26828671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ocular delivery of cyclosporine A based on glyceryl monooleate/poloxamer 407 liquid crystalline nanoparticles: preparation, characterization, in vitro corneal penetration and ocular irritation.
    Chen Y; Lu Y; Zhong Y; Wang Q; Wu W; Gao S
    J Drug Target; 2012 Dec; 20(10):856-63. PubMed ID: 23050903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natamycin niosomes as a promising ocular nanosized delivery system with ketorolac tromethamine for dual effects for treatment of candida rabbit keratitis; in vitro/in vivo and histopathological studies.
    El-Nabarawi MA; Abd El Rehem RT; Teaima M; Abary M; El-Mofty HM; Khafagy MM; Lotfy NM; Salah M
    Drug Dev Ind Pharm; 2019 Jun; 45(6):922-936. PubMed ID: 30744431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.